Tabula Rasa HealthCare (NASDAQ:TRHC) had its price objective upped by Chardan Capital from $77.00 to $91.00 in a research report report published on Wednesday. They currently have a buy rating on the stock.

A number of other equities analysts have also commented on the stock. Cantor Fitzgerald restated a buy rating and issued a $99.00 price target on shares of Tabula Rasa HealthCare in a research report on Tuesday. BidaskClub upgraded shares of Tabula Rasa HealthCare from a hold rating to a buy rating in a research report on Tuesday. Citigroup boosted their price target on shares of Tabula Rasa HealthCare to $100.00 and gave the company a buy rating in a research report on Thursday, October 11th. Robert W. Baird boosted their price target on shares of Tabula Rasa HealthCare from $70.00 to $90.00 and gave the company an outperform rating in a research report on Wednesday, September 19th. Finally, Stifel Nicolaus began coverage on shares of Tabula Rasa HealthCare in a research report on Tuesday, September 11th. They issued a hold rating and a $95.00 price target on the stock. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and eleven have assigned a buy rating to the company. The company currently has a consensus rating of Buy and a consensus target price of $81.60.

NASDAQ TRHC traded down $0.85 on Wednesday, reaching $72.96. The company’s stock had a trading volume of 289,922 shares, compared to its average volume of 340,137. The stock has a market cap of $1.52 billion, a P/E ratio of -1,824.00, a PEG ratio of 5.63 and a beta of 2.58. Tabula Rasa HealthCare has a 52 week low of $27.10 and a 52 week high of $91.16. The company has a quick ratio of 0.33, a current ratio of 0.49 and a debt-to-equity ratio of 0.28.

Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its earnings results on Tuesday, November 6th. The company reported $0.26 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.19 by $0.07. The business had revenue of $54.42 million for the quarter, compared to analysts’ expectations of $52.87 million. Tabula Rasa HealthCare had a negative net margin of 13.49% and a positive return on equity of 7.63%. The firm’s revenue for the quarter was up 66.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.08 earnings per share. Research analysts anticipate that Tabula Rasa HealthCare will post 0.52 earnings per share for the current year.

In other Tabula Rasa HealthCare news, CEO Calvin H. Knowlton sold 8,000 shares of the business’s stock in a transaction dated Wednesday, November 7th. The shares were sold at an average price of $72.13, for a total value of $577,040.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Over the last 90 days, insiders sold 48,000 shares of company stock worth $3,722,960. Company insiders own 14.00% of the company’s stock.

A number of large investors have recently added to or reduced their stakes in TRHC. American International Group Inc. lifted its position in shares of Tabula Rasa HealthCare by 6.0% during the third quarter. American International Group Inc. now owns 13,664 shares of the company’s stock worth $1,109,000 after purchasing an additional 772 shares in the last quarter. Chicago Equity Partners LLC lifted its position in shares of Tabula Rasa HealthCare by 6.4% during the third quarter. Chicago Equity Partners LLC now owns 15,050 shares of the company’s stock worth $1,222,000 after purchasing an additional 900 shares in the last quarter. Mckinley Capital Management LLC Delaware lifted its position in shares of Tabula Rasa HealthCare by 60.5% during the second quarter. Mckinley Capital Management LLC Delaware now owns 2,431 shares of the company’s stock worth $155,000 after purchasing an additional 916 shares in the last quarter. State of Alaska Department of Revenue lifted its position in shares of Tabula Rasa HealthCare by 22.4% during the third quarter. State of Alaska Department of Revenue now owns 5,445 shares of the company’s stock worth $442,000 after purchasing an additional 995 shares in the last quarter. Finally, Louisiana State Employees Retirement System lifted its position in shares of Tabula Rasa HealthCare by 21.3% during the third quarter. Louisiana State Employees Retirement System now owns 7,400 shares of the company’s stock worth $601,000 after purchasing an additional 1,300 shares in the last quarter. Hedge funds and other institutional investors own 75.88% of the company’s stock.

About Tabula Rasa HealthCare

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

Further Reading: What is the yield curve?

Analyst Recommendations for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.